Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 33 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 11 | 619+0.2%/yr | +0.2%/yr | 3.51.1× | 16% | 820 in 2030+4.7%/yr |
| Lumbar fusion | 12 | 599−2.6%/yr | −2.6%/yr | 3.41.1× | 10% | 670 in 2030+2%/yr |
| Cervical fusion & disc arthroplasty | 7 | 283−1.8%/yr | −1.8%/yr | 1.61.0× | 15% | 360 in 2030+4%/yr |
| Kyphoplasty & vertebroplasty | 2 | 124−1.1%/yr | −1.1%/yr | 0.70.4× | 32% | 260 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 57 | 12,034+3.1%/yr | +3.1%/yr | 68.10.6× | 37% | 18,400 in 2030+7.3%/yr |
| Skin substitutes & wound grafts | 5 | 1,763+16%/yr | +16%/yr | 7.80.7× | 92% | 3,650 in 2030+13%/yr |
| Bone graft & orthobiologics | 7 | 334−2.8%/yr | −2.8%/yr | 1.92.8× | 11% | 340 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 24 | 1,803+8.7%/yr | +8.7%/yr | 10.20.7× | 100% | 3,040 in 2030+9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 8 | 910−1%/yr | −1%/yr | 5.20.8× | 79% | 2,020 in 2030+14%/yr |
| Dialysis access | 7 | 781−12%/yr | −12%/yr | 4.70.8× | 89% | 780 in 20300%/yr |
| Superficial venous ablation | 7 | 284−5.2%/yr | −5.2%/yr | 1.60.3× | 100% | 440 in 2030+7.4%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 241−1%/yr | −1%/yr | 1.40.8× | 44% | 850 in 2030+23%/yr |
| Carotid revascularization | 10 | 186−2.9%/yr | −2.9%/yr | 1.10.8× | 0% | 180 in 2030−0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 10 | 997−4.5%/yr | −4.5%/yr | 6.01.0× | 5% | 1,250 in 2030+3.9%/yr |
| Cholecystectomy & appendectomy | 14 | 605−4.5%/yr | −4.5%/yr | 3.60.8× | 0% | 740 in 2030+3.5%/yr |
| Colorectal resection | 2 | 264−6.1%/yr | −6.1%/yr | 1.60.9× | 0% | 340 in 2030+4.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 19 | 805−2.9%/yr | −2.9%/yr | 4.70.9× | 31% | 860 in 2030+1.1%/yr |
| BPH procedures | 11 | 729−4.8%/yr | −4.8%/yr | 4.20.9× | 45% | 790 in 2030+1.4%/yr |
| Hysterectomy, hysteroscopy & ablation | 8 | 418−3.4%/yr | −3.4%/yr | 2.61.0× | 13% | 530 in 2030+4.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 3 | 284−1.8%/yr | −1.8%/yr | 1.60.6× | 0% | 370 in 2030+4.5%/yr |
| Prostatectomy & nephrectomy | 1 | 105−3.9%/yr | −3.9%/yr | 0.60.5× | 0% | 90 in 2030−3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 6 | 435−5.7%/yr | −5.7%/yr | 2.60.5× | 88% | 480 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 19 | 1,063−4.7%/yr | −4.7%/yr | 6.50.9× | 26% | 1,140 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 25 | 4,890+35%/yr | +35%/yr | 28.21.0× | 80% | 8,660 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 13 | 724−4.8%/yr | −4.8%/yr | 4.30.8× | 0% | 790 in 2030+1.4%/yr |
| LAA occlusion & loop recorders | 17 | 625+4.5%/yr | +4.5%/yr | 3.30.9× | 31% | 810 in 2030+4.3%/yr |
| EP ablation | 7 | 268+0.4%/yr | +0.4%/yr | 1.40.4× | 0% | 330 in 2030+3.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 21 | 734−9.5%/yr | −9.5%/yr | 3.80.6× | 0% | 780 in 2030+0.9%/yr |
| Structural heart (TAVR, TEER) | 16 | 290+19%/yr | +19%/yr | 1.51.0× | 0% | 520 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 21 | 8,893+2%/yr | +2%/yr | 51.30.9× | 94% | 10,900 in 2030+3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 61 | 18,560−2.7%/yr | −2.7%/yr | 110.80.9× | 57% | 21,200 in 2030+2.2%/yr |
| Bronchoscopy & lung nodule | 12 | 798+6.5%/yr | +6.5%/yr | 4.71.4× | 0% | 1,560 in 2030+12%/yr |
| ERCP & endoscopic ultrasound | 10 | 417−1.5%/yr | −1.5%/yr | 2.50.7× | 0% | 470 in 2030+2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.